Lupin Ltd has launched generic Tolvaptan tablets in the US, after receiving USFDA approval. These tablets, with strengths of 15 mg, 30 mg, ...

Lupin, a pharmaceutical company, has launched a new subsidiary named Lupin Manufacturing Solutions (LMS) to enter the Contract Development ...

Pharmaceuticals firm Lupin Ltd on Friday said it will fully acquire French pharmaceutical company Medisol for 18 million euros (over Rs 160...

Spiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...

The acquisition enhances the company's scale in the US generic market and also broadens its pipeline in dermatology and controlled substanc...

"Lupin is a 'SELL' call with a target of Rs 1,719 and a stop loss of Rs 1,840."

"Lupin is a 'SELL' call with a target of Rs 1881 and a stop loss of Rs 1970"

The Latin American region is a market of strategic focus for the company and one of the fastest growing pharmaceutical markets globally, sh...

A day after announcing its biggest acquisition deal of $880 million, Lupin today said it will buy Germany-based Temmler Pharma's specialty ...

'Lupin Ltd is a 'SELL' call with a target of Rs 1,580 and a stop loss of Rs 1,739'

'Buy Lupin Ltd with a target of Rs 1775 and a stop loss of Rs 1665'

Lupin has set up a dedicated centre of excellence for inhalation research in Florida after having hired top notch inhalation scientists las...

'Lupin Ltd is a 'BUY' call with a target of Rs 1566 and a stop loss of Rs 1478.'

'Lupin Ltd is a 'BUY' call with a target of Rs 1485 and a stop loss of Rs 1394.'

Buy Lupin with stop loss of Rs 1160 for target of Rs 1220.

"Lupin is a 'BUY' call with a target of Rs 1,145 and a stop loss of Rs 1,080."

Lupin is a 'BUY' call with a target of Rs 1005 and a stop loss of Rs 965.